Hämatologische Neoplasien
und solide Tumoren in der Schwangerschaft

H. Popp; K. Spiekermann; A. Wollenberg; C. Spitzweg; B. Loehrs

doi:10.1055/s-0028-1124006

DMW - Deutsche Medizinische Wochenschrift, Table of Contents

Dtsch Med Wochenschr 2009; 134(8): 361-364
DOI: 10.1055/s-0028-1124006

Aktuelle Diagnostik & Therapie | Review article

Geburtshilfe, Hämatologie, Onkologie
© Georg Thieme Verlag KG Stuttgart · New York

Hämatologische Neoplasien und solide Tumoren in der Schwangerschaft

Teil 2: Spezielle TherapieHematologic neoplasias and solid tumors in pregnancy Part 2: Specific treatmentH. Popp¹ , K. Spiekermann¹ , A. Wollenberg² , C. Spitzweg³ , B. Loehrs⁴

¹Medizinische Klinik und Poliklinik III – Großhadern, Klinikum der Universität München
²Klinik und Poliklinik für Dermatologie und Allergologie, Ludwig-Maximilians Universität München
³Medizinische Klinik und Poliklinik II – Großhadern, Klinikum der Universität München
⁴Klinik und Poliklinik für Frauenheilkunde und Geburtshilfe – Großhadern, Klinikum der Universität München

Abstract

Schlüsselwörter

Hämatologische Neoplasien - Solide Tumoren - Schwangerschaft

Keywords

hematological neoplasias - solid tumours - pregnancy

Full Text

References

Literatur

1 Abalovich M. et al . Management of thyroid dysfunction during pregnancy and postpartum: An Endocrine Society Clinical Practice Guideline. J Clin Endocrinol Metab. 2007; 92 1-47
2 Adelstein S J. Administered radionuclides in pregnancy. Teratology. 1999; 59 236-239
3 Albo D, Wayne J D, Hunt K K. et al . Anaphylactic reactions to isosulfan blue dye during sentinel lymph node biopsy for breast cancer. Am J Surg. 2001; 182 93-98
4 Alexander A. et al . Metastatic melanoma in pregnancy: risk of transplacental metastases in the infant. J Clin Oncol. 2003; 21 2179-2186
5 Ali R, Ozkalemkas F, Ozkocaman V. Successful pregnancy and delivery in a patient with chronic myelogenous leukemia (CML), and management of CML with leukapheresis during pregnancy: a case report and review of the literature. Jpn J Clin Oncol. 2004; 34 (4) 215-217
6 Aviles A, Diaz-Maqueo J C, Talavera A. Growth and development of children of mothers treated with chemotherapy during pregnancy: current status of 43 Children. Am J Hematol. 1991; 36 243-248
7 Breccia M, Cimino G, Mandelli F. AIDA treatment for high-risk acute promyelocytic leukemia in a pregnant woman at 21 weeks of gestation. Haematologica. 2002; 87 12
8 Celo J S, Kim H C, Saidi P. Acute promyelocytic leukemia in pregnancy: all-trans retinoic acid as a newer therapeutic option. Obstet Gyncol. 1994; 83 808-811
9 Cimmino V M, Brown A C, Szocik J F. et al . Allergic reactions to isosulfan blue during sentinel node biopsy – a common event. Surgery. 2001; 130 439-442
10 Delgada-Lamas J L, Garces-Ruiz O M. Acute promyelocytic leukemia in late pregnancy. Successful treatment with all-trans-retinoic acid (ATRA) and chemotherapy. Hematology. 2000; 4 415-418
11 Garbe C. et al . Evidence-based and interdisciplinary consensus-based German guidelines: systemic medical treatment of melanoma in the adjuvant and palliative setting. Melanoma Res. 2008; 18 152-160
12 Janni W. Manual Mammakarzinome. Empfehlungen zur Diagnostik, Therapie und Nachsorge. 11. Auflage, ISBN: 978-3-88603-909-9. TUZ München 2007
13 Janni W. Treatment of pregnancy associated gynaecological malignancies. Zentralbl Gynakol. 2006; 128 (3) 129-134
14 Kuerer H M, Gwyn K, Theriault R L. Conservative surgery and chemotherapy for breast carcinoma during pregnancy. Surgery. 2002; 131 108-110
15 Loibl S. et al . Breast carcinoma during pregnancy. International recommendations from an expert meeting. Cancer. 2006; 106 237-246
16 Moosa M, Mazzaferri E L. Outcome of differentiated thyroid cancer diagnosed in pregnant women. J Clin Endocrinol Metab. 1997; 82 2862-2866
17 Oehler M K, Wain G V, Brand A. Gynaecological malignancies in pregnancy: a review. Aust N Z J Obstet Gynaecol. 2003; 43 (6) 414-420
18 Pavlidis N, Pentheroudakis G. Metastatic involvement of placenta and foetus in pregnant women with cancer. Recent Results Cancer Res. 2008; 178 183-194
19 Siu B L, Alonzo M R, Fenrich A L. Transient dilated cardiomyopathy in a newborn exposed to idarubicin and all-trans-retinoic acid (ATRA) early in the second trimester of pregnancy. Int J Gynecol Cancer. 2002; 12 399-402
20 Shapira T, Pereg D, Lishner M. How I treat acute and chronic leukemia in pregnancy. Blood Rev. 2008; 22 247-259
21 Steenvoorde P, Pauwels E K, Harding L K. et al . Diagnostic nuclear medicine and risk for the fetus. Eur J Nucl Med. 1998; 25 193-199
22 Timins J K. Radiation during pregnancy. N J Med. 2001; 98 29-33
23 Watson W J. Herceptin (trastuzumab) therapy during pregnancy: association with reversible anhydramnions. Obstet Gynecol. 2005; 105 642
24 Wyatt R M, Dale R G. The effect of delay in radiotherapy treatment on tumour control. Phys Med Biol. 2003; 48 139-155

Dr. med. Henning Popp

Medizinische Klinik und Poliklinik III, Klinikum der Universität München – Großhadern

Marchioninistr. 15

81377 München

Email: Henning.Popp@med.uni-muenchen.de